Member Info for LordSnooty

Intensity Therapeutics will be formally presenting INT230-6 data at The New York Academy of Sciences' Frontiers in Cancer Immunotherapy Symposium on May 14-15 2019 in New York, NY.

the Factom Protocol in 62 seconds:
https://youtu.be/q977U_ntZIA

Well, rule No.1 on AIM - never say never, but that applies to the upside too, and with the right news flow we could easily double and more from here. It all depends.

Not me - "...looking forward to a very exciting May for us and the Factom Protocol." - Factom Blog:
https://www.factom.com/company/blog/april-2019-ano-update/

Ridiculous Price

Agreed, and in addition, unless it's a firesale, in the case of our portfolio the sale of assets would likely realise well in excess of the last-published NAV.

As robrob said earlier, looks like some arbitraging - the volume is incrementally larger than usual:
https://www.coingecko.com/en/coins/factom

Some remarkably cogent and lucid posts from you yesterday, many of which I agree with. No sense in fussing over selling part of Vemo for a small loss, it was marked down in the last NAV anyway, and if the cash can be put to work elsewhere soon, so much the better. Clearly Abony has his beady eye on something in the dope line that catches his fancy, and wants to be in like the proverbial rat up a drainpipe, to mix a few ill-chosen metaphors.
I don't foresee much downside from here, there's still lots still to play for at FFWD - no need to rehearse the names again. Ut Fidem!

"Following the passage of the U.S. Farm Bill, hemp and its derivatives, extracts and cannabinoids, including hemp CBD, are no longer classified as Schedule I substances and are now federally legal. The market for products containing CBD was estimated to be $591 million in 2018 and projected to increase nearly 40 times to $22 billion by 2022, according to Brightfield Group research. Hemp CBD is also in line with the longer-term health and wellness trend that continues to drive consumer demand."

Up 22%+ on the day so far. Could be just crypto euphoria - or something's up Factomwise as you say, Matador.

Sorry, I'm wrong, Fralis is of course public, but perhaps either still in nevis, or in Israel?

They used to be registered in Nevis, so if they still are, and as you say, Israelis are involved, good luck with getting any financial information out of a private company under those circumstances. Doggie is the go-to man for info, I think. Their tie-up with IMG seems to have been productive, but I doubt there are any publicly published figures.

I was never a big fan of Vemo, so if push comes to shove I'm glad we disposed of most of our holding at better than last-booked value. But this is surely only the first step in an unfolding story, and in the nature of business we can't know exactly how it will develop. I do take some comfort, though, in the fact that Abony is in at 17-18p, last August's placing was at 13p, and that at present markets are 'dire', but will inevitably recover. But if Abony does spy a good opportunity, would he do a placing at, say 9 or 10p under present circumstances? Or could the sale of, say, Leap, or any other assets, provide the necessary funds for his plans?

I think it's a little premature to say it's becoming 'dire'; nobody seems to have noticed that Vemo was discounted in the last Interims, so in one sense receiving more than the company was booked for there is good news. But be that as it may, we don't know what further sales steps Abony is planning, nor the target which he surely must be fixed upon in the medicinal cannabis sector. Until that becomes clearer, and as long as the NAV is going in the right direction, I'll hang fire. Remember, there are still multiple other investee sources that will report in coming months, starting with Insilico on Wednesday.

just itching to take it lower again. This news was, once again, not the news that the market hoped for.

So £63k better than last Interims, plus they've retained 1m of the more valuable preferred shares.

they have retained 0.47% of Vemo in Series 2 preferred shares.

but I'd say our next disposal will net us more than a few more millions for the Pot.

of why people are so quick to take profit where they can on AIM - a great company with a diversified portfolio of companies with phenomenal growth and earnings potential, a solid track record of NAV increases over successive annual and interim reports, some terrific major investors, a recent placing at 13p which was already discounted - and the stock hits a new recent low.

AgeX up bigly on Friday. Bitcoin up bigly today. Insilico presenting results in St Petersburg this Wednesday. Ed to throw Doggo a bone soon?